Latest filing published 18 Aug 2026 for AbbVie Inc., €2.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Nicholas Donoghoe in AbbVie Inc. The record holds 17 filings, for trades running from 26 December 2023 to 14 August 2026.
Every open-market trade on record is a sale: 4 sales worth €11.5M. Besides market trades, the filings include 12 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 18 August 2026: an option exercise of €2.2M, in AbbVie Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations